CONMED Corporation Announces Third Quarter 2009 Financial Results
CardiacAssist expands market penetration of TandemHeart
ConjuChem Announces Fiscal 2009 Third Quarter Financial Results
Valeant Pharmaceuticals to Announce 2009 Third Quarter Results on November 2, 2009
Comment on Media Report on Forecast for AGC's Financial Results
To keep up to date with news from this category use our
MDRNA, Inc. Announces Third Quarter 2009 Financial Results
BOTHELL, WA, November 12, 2009 -- MDRNA, Inc. (NASDAQ: MRNA) today reported financial results for the three- and nine-month periods ended September 30, 2009. Net loss for the third quarter of 2009 was approximately $7.0...
MediciNova Reports Third Quarter 2009 Results
SAN DIEGO, Calif., November 12, 2009 -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code...
Isotechnika Pharma reports third quarter 2009 financial results
EDMONTON, November 11, 2009 - Isotechnika Pharma Inc. (TSX:ISA) today announced its financial results for the third quarter ended September 30, 2009.
InSite Vision Reports Third Quarter 2009 Financial Results
ALAMEDA, Calif.-- November 11, 2009-- InSite Vision Incorporated (OTCBB: INSV) today reported financial results for the quarter ended September 30, 2009. Total revenue for the third quarter of 2009 was $2.2 million with...
GeneNews announces third quarter results
TORONTO, CANADA (November 11, 2009): GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported...
Natural Alternatives International, Inc. Announces Fiscal 2010 Q1 Results
SAN MARCOS, Calif., November 11, 2009 -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income...
Dynatronics To Release First Quarter Results
Salt Lake City, Utah (November 11, 2009) - Dynatronics Corporation (NASDAQ: DYNT) plans to release financial results for its quarter ended September 30, 2009 during the morning of Friday, November 13, 2009.
Company Announcement no. 21/2009: LifeCycle Pharma Announces Result for the First Nine Months of 2009 and Improves Once Again the Full Year Outlook
November 11, 2009 -- LifeCycle Pharma A/S (OMX:LCP) today announced the Interim Report for the 9 months ended September 30, 2009 and reported in line with expectations a net loss of DKK 211.2 million for the first nine...
YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
MISSISSAUGA, ON, Nov. 11, 2009- YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various...
CML HealthCare Income Fund Reports 2009 Third Quarter Financial Results
MISSISSAUGA, ON, Nov. 11 - CML HealthCare Income Fund (the "Fund" or "CML HealthCare"), (TSX: CLC.UN) today reported its financial results for the three and nine-month periods ended September 30, 2009 (all amounts are...
Epigenomics AG Reports Q3 and Nine Months 2009 Results
Press release, Berlin, Germany, and Seattle, WA, U.S.A., November 10, 2009 -- The molecular diagnostics company Epigenomics AG (Frankfurt Prime Standard: ECX) today reported financial results for the third quarter and...
SYGNIS reports on second quarter 2009/2010
Heidelberg, November 10, 2009 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today published its financial results for the second quarter and the first half of the fiscal year 2009/2010, which...
Akorn Reports Third Quarter 2009 Financial Results; Launches Two New Products: Ketorolac Tromethamine Ophthalmic and Hydralazine HCL
LAKE FOREST, Ill.--November 10, 2009--Akorn, Inc. (NASDAQ: AKRX) a specialty pharmaceutical company, today reported financial results for the third quarter ended September 30, 2009.
ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results
SAN DIEGO, Nov. 10 -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and nine months ended September 30, 2009.
Advanced Life Sciences Announces Third Quarter 2009 Financial Results
CHICAGO, Nov. 10-- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of...
CORCEPT THERAPEUTICS ANNOUNCES RECENT HIGHLIGHTS AND THIRD QUARTER 2009 FINANCIAL RESULTS
MENLO PARK, Calif., (November 10, 2009) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic and...
VION PHARMACEUTICALS REPORTS 2009 THIRD QUARTER AND NINE-MONTH RESULTS
NEW HAVEN, CT, November 10, 2009 - VION PHARMACEUTICALS, INC. (OTC BULLETIN BOARD: VION) today announced financial results for the three-month and ninemonth periods ending September 30, 2009.
Cardiogenesis Reports Third Quarter 2009 Results
IRVINE, Calif., Nov. 10 -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today reported financial results for its...
Transition Therapeutics Announces First Quarter Fiscal 2010 Financial Results
TORONTO, Nov. 10, 2009 - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for disease indications with large...
Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
SAN DIEGO, Nov 09, 2009-- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the third quarter ended September 30, 2009.
Maxygen Reports Third Quarter 2009 Financial Results
REDWOOD CITY, Calif., November 5, 2009 -- Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, today announced financial results for the quarter ended September 30,...
Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results
CAMBRIDGE, Mass., November 04, 2009 -- Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV) announced today that its CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, will host a conference call to discuss the Company's...
Henry Schein Reports Record Third Quarter Results
MELVILLE, N.Y., November 4, 2009 -- Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter...
Given Imaging Reports Third Quarter 2009 Results
YOQNEAM, ISRAEL, November 04, 2009 -- Given Imaging Ltd. (NASDAQ: GIVN) today announced financial results for the third quarter ended September 30, 2009.
SurModics Reports Fourth Quarter and Fiscal Year 2009 Results
EDEN PRAIRIE, Minn.---Nov. 4, 2009-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, today reported financial results for the fourth...
Santarus Reports Third Quarter 2009 Financial Results
SAN DIEGO----Nov. 4, 2009-- Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today reported financial and operating results for the quarter ended September 30, 2009. Key financial results for the...
Chembio Reports Third Quarter 2009 Results
MEDFORD, NY, Nov 04, 2009 -- Chembio Diagnostics, Inc. (OTCBB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, continued its profitability into the third quarter of 2009. Total...
AtriCure Reports Third Quarter 2009 Financial Results
WEST CHESTER, Ohio - November 4, 2009 - AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced revenues of $13.3 million for its seasonally light third...
Osiris Therapeutics Reports Third Quarter 2009 Financial Results
COLUMBIA, Maryland - November 4, 2009 - Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory,...
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update
THE WOODLANDS, Texas--November 04, 2009---Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended...
Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results
CARY, N.C., Nov. 4 -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related...
Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6
BRANFORD, Conn.-- November 4, 2009-- Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its third quarter 2009 financial results on Friday, November 6, 2009 before the...
CML HealthCare Income Fund Announces Release Date for Fiscal 2009 Third Quarter Financial Results
MISSISSAUGA, ON, Nov. 4 - CML HealthCare Income Fund (TSX: CLC.UN), will release its 2009 third quarter financial results via www.newswire.ca prior to markets opening on November 11th , 2009. Following the release, CML...
Luminex Corporation Reports Third Quarter 2009 Results
AUSTIN, Texas-- November 4, 2009-- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the third quarter ended September 30, 2009. Recent financial and operating highlights include the following:
OraSure Announces 2009 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 4, 2009 -- OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced revenues of $21.6 million for the three months ended September 30, 2009, compared to...
Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
MORRISTOWN, N.J., Nov. 4, 2009-- Watson Pharmaceuticals, Inc. (NYSE: WPI) today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as...
Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
NEEDHAM, Mass.--Nov. 4, 2009-- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results for the third quarter and nine-month period ended September 30, 2009. Celldex reported a net loss of $7.2...
Cyclacel Announces Third Quarter 2009 Financial Results
Berkeley Heights, NJ, November 3, 2009 - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") announced today financial and operating results for the third quarter of 2009. The...
Bio-Rad Laboratories, Inc. (BIO) Reports Third-Quarter Currency-Neutral Revenue Growth of 11 Percent
HERCULES, CA--(November 03, 2009) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial...
Masimo Reports Third Quarter 2009 Financial Results
Irvine, California, November 3, 2009 - Masimo Corporation (NASDAQ: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced its financial results for the...
Third quarter 2009 report - Lundbeck records 20% growth, driven by Lundbeck Inc. and key products
November 03, 2009 -- H. Lundbeck A/S (Lundbeck) reports third quarter revenue of DKK 3,264 million growing 20% in constant exchange rates compared to the third quarter of 2008. Revenue in the US was DKK 959 million...
AGA Medical Reports 2009 Third Quarter Financial Results
MINNEAPOLIS, Nov. 3, 2009 -- AGA Medical Holdings (NASDAQ: AGAM), a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular disease, today...
AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2009
BOSTON, Nov. 3 -- AMICAS, Inc. (NASDAQ: AMCS), a leader in image and information management solutions, today reported unaudited financial results for the third quarter ended September 30, 2009.
VIKING SYSTEMS, INC. REPORTS THIRD QUARTER RESULTS; PROVIDES BUSINESS UPDATES
Westborough, MA, November 3, 2009 -- Viking Systems, Inc. (OTCBB: VKNG.OB), a supplier of 2D and 3D visualization systems for the medical market, today announced results for the quarter ended September 30, 2009. The...
XenoPort Reports Third Quarter Financial Results
SANTA CLARA, Calif.---Nov. 3, 2009-- XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2009. Revenues for the third quarter were $0.4 million,...
VIVUS Reports Third Quarter 2009 Highlights and Financial Results
MOUNTAIN VIEW, Calif., Nov 03, 2009 -- VIVUS,Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its highlights and financial...
Clarient Reports 2009 Third Quarter; Nine Month Results
ALISO VIEJO, Calif., Nov. 3 -- Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today reported financial...
CardiacAssist expands market penetration of TandemHeart
PITTSBURGH, Nov. 2, 2009--Privately held CardiacAssist Inc. announced today that the Cardiovascular Institute of Stanford (University) Hospital & Clinics (Palo Alto, Calif.) is one of the newest cardiac centers to begin...
Questcor Announces Third Quarter 2009 Results
UNION CITY, Calif., Nov. 2, 2009-- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today reported financial results for its third quarter ended September 30, 2009. As previously reported on September 21, 2009, Questcor's...
Haemonetics Reports Double Digit Growth in Earnings for Second Quarter Fiscal 2010
Braintree, MA , November 2, 2009 - Haemonetics Corporation (NYSE: HAE) reported second quarter GAAP net revenues of $157 million, up 8%, net income of $18 million, up 22%, and earnings per share of $0.69, up 20%....
MANNKIND CORPORATION REPORTS THIRD QUARTER FINANCIAL RESULTS
November 02, 2009 -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the third quarter ended September 30, 2009.
MannKind Corporation Reports Third Quarter Financial Results
VALENCIA, Calif.-- November 2, 2009-- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the third quarter ended September 30, 2009.
Valeant Pharmaceuticals Reports Third Quarter Financial Results
ALISO VIEJO, Calif., Nov. 2, 2009-- Valeant Pharmaceuticals International (NYSE: VRX) today announced third quarter financial results for 2009.
Natus Medical Announces 2009 Third Quarter Financial Results and Increases Fourth Quarter and Full Year 2009 Guidance
SAN CARLOS, Calif., November 02, 2009 -- Natus Medical Incorporated (Nasdaq:BABY) today announced financial results for the three and nine months ended September 30, 2009.
UROPLASTY REPORTS RESULTS FOR SECOND QUARTER FY2010
MINNEAPOLIS, MN, November 2, 2009 - Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported...
Tredegar Reports Third-Quarter Results
RICHMOND, Va., Nov. 2 , 2009-- Tredegar Corporation (NYSE: TG) reported third-quarter net income from continuing operations of $11.0 million (32 cents per share) compared to $11.1 million (33 cents per share) in the...
Vanda Pharmaceuticals Reports Third Quarter 2009 Results
ROCKVILLE, Md., Nov 02, 2009 -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system...
Torrent Pharma's Q2 operating profits jump 83% at Rs. 118 crores
October 31st, 2009 - Ahmedabad-based Torrent Pharmaceuticals Limited, released its financial results for second quarter (Q2) and half year ended (H1) 30th September, 2009. The Q2 global sales stood at Rs. 465 crores, up...
Talecris Biotherapeutics to Report Third Quarter 2009 Financial Results
RESEARCH TRIANGLE PARK, N.C.---Oct. 30, 2009-- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its third quarter 2009 financial results on November 9, 2009, after the stock market closes, and will...
Cytomedix To Host Third Quarter And Nine Months 2009 Financial Results Conference Call On Thursday, November 12, 2009
ROCKVILLE, Md. (October 30, 2009) - Cytomedix, Inc. (NYSE Amex: GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company...
Pain Therapeutics Reports Third Quarter 2009 Results
SAN MATEO, Calif., Oct. 29, 2009 -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reported financial results for the quarter ended September 30, 2009.
Endologix Reports 47% Third Quarter 2009 Revenue Growth
IRVINE, Calif., October 27, 2009 -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30,...
ALPHA PRO TECH, LTD. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2009
Nogales, Arizona - October 27, 2009, Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building...
Building Brands and gathering Momentum across Markets
Mumbai, October 26, 2009: Leading transnational pharmaceutical major Lupin, reported strong performance for the second quarter - FY 2009-10. These audited results were taken on record by the Board of Directors at a...
Valeant Pharmaceuticals to Announce 2009 Third Quarter Results on November 2, 2009
ALISO VIEJO, Calif., Oct. 23, 2009- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, November...
Orthovita, Inc. (VITA) Announces 2009 Third Quarter Sales
MALVERN, Pa.--October 23, 2009--Orthovita, Inc. (NASDAQ:VITA), a leading orthobiologics and biosurgery company, today announced that product sales for the third quarter of 2009 were $22.3 million, an 8% increase over...
CONMED Corporation Announces Third Quarter 2009 Financial Results
UTICA, NY, Oct 22, 2009-- CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.
Report of NicOx's financial results for the first three quarters of 2009
October 22, 2009. Sophia Antipolis, France. www.nicox.com NicOx S.A. (Euronext Paris: COX) today reported financial results for the nine months ended September 30, 2009.
ALPHA PRO TECH, LTD. TO ANNOUNCE 2009 THIRD QUARTER RESULTS ON OCTOBER 27, 2009
NOGALES, ARIZONA - October 21, 2009 -- Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and...
Trinity Biotech Announces Third Quarter 2009 Financial Results
DUBLIN, Ireland (October 21, 2009).... Trinity Biotech plc (NasdaqGS: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for...
Comment on Media Report on Forecast for AGC's Financial Results
October 21, 2009 Today's media report on the forecast for AGC's financial results for FY 2009 is not based on any announcement by AGC. AGC will announce the financial results for FY 2009 in February, 2010.
Genzyme Reports Third-Quarter Financial Results
October 21, 2009 - Genzyme Corp. (NASDAQ: GENZ) today reported that third-quarter revenue was $1.06 billion, compared with $1.16 billion in the same period a year ago. Results reflect the impact of the temporary...
API records strong growth and increased profit Announces $150m equity raising
October 21, 2009 Australian Pharmaceutical Industries (ASX: API), a leading Australian healthcare company and one of Australia's leading health and beauty retailers, today reported stronger than expected results for the...
UROPLASTY TO ISSUE SECOND FISCAL QUARTER RESULTS ON NOVEMBER 2, 2009
MINNEAPOLIS, MN, October 21, 2009 - Uroplasty, Inc. (AMEX: UPI) announced today that it will release financial results for the second fiscal quarter ended September 30, 2009, at the market close on Monday, November 2,...
Air Products Reports Fiscal Q4 EPS from Continuing Operations of $1.14
LEHIGH VALLEY, Pa. (October 21, 2009) - Air Products today reported income from continuing operations of $246 million, or diluted earnings per share (EPS) of $1.14, for its fiscal 2009 fourth quarter versus $273 million...
ERT to Announce 2009 Third Quarter Results on October 29, 2009
PHILADELPHIA, PA October 21, 2009 - ERT (NASDAQ: ERES), a leading provider of centralized ECG, ePRO, eClinical technology, and other services to the biopharmaceutical, medical device, and related industries, announced...
Bard Announces Third Quarter Results
MURRAY HILL, N.J.--Oct. 21, 2009-- C. R. Bard, Inc. (NYSE: BCR) today reported 2009 third quarter financial results. Third quarter 2009 net sales were $637.0 million, an increase of 3 percent over the prior-year period....
Privately held CardiacAssist reports record revenues for nine-month financial results Company's TandemHeart
PITTSBURGH, Oct. 19, 2009--Privately held CardiacAssist Inc. announced today nine-month financial results for 2009. TandemHeart System revenues were at new record levels compared to results for the same period in 2008.
Hansen Medical Announces Need to Restate Prior Financial Results
MOUNTAIN VIEW, CA, Oct 19, 2009 -- Hansen Medical, Inc. (NASDAQ: HNSN) today announced that it plans to restate its financial statements for the year ended December 31, 2008 and for the quarters ended March 31, 2008,...
ConjuChem Announces Fiscal 2009 Third Quarter Financial Results
MONTREAL, Canada, September 14, 2009 - ConjuChem Biotechnologies (TSX:CJB) today announced financial results for the third quarter of fiscal 2009, ended July 31, 2009. "During our fiscal third quarter, we had the...
Luna Innovations Reports Second Quarter 2009 Financial Results; Luna Continues Listing on NASDAQ
ROANOKE, Va.-- September 9, 2009-- Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced its financial results for the quarter...
Second Quarter Report 2009
Oslo, Norway, 27 August 2009--During the second quarter Clavis Pharma announced the successful completion of a Phase II study of its lead development candidate, elacytarabine, in late-stage acute myeloid leukaemia...
HydroCision Announces Record Revenue Performance in Second Quarter
North Billerica, MA August 17, 2009-HydroCision Inc. (www.hydrocision.com) announced today that revenue for the second quarter of 2009 increased by 43% over the same fiscal quarter 2008. Trailing quarter product sales...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
